Citadel Advisors
GDRX icon

Citadel Advisors’s GoodRx Holdings GDRX Stock Holding History

Citadel Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Buy
85,800
+44,200
+106% +$104K ﹤0.01% 11585
2025
Q4 		$113K Buy
+41,600
New +$137K ﹤0.01% 11536
2025
Q3 		– Sell
-61,900
Closed -$308K – 13249
2025
Q2 		$308K Sell
61,900
-133,300
-68% -$579K ﹤0.01% 9750
2025
Q1 		$861K Buy
195,200
+187,100
+2,310% +$878K ﹤0.01% 7297
2024
Q4 		$37.7K Sell
8,100
-120,300
-94% -$661K ﹤0.01% 12661
2024
Q3 		$891K Buy
128,400
+14,000
+12% +$110K ﹤0.01% 7100
2024
Q2 		$892K Buy
114,400
+35,000
+44% +$259K ﹤0.01% 6823
2024
Q1 		$564K Sell
79,400
-96,000
-55% -$635K ﹤0.01% 8117
2023
Q4 		$1.18M Sell
175,400
-44,900
-20% -$253K ﹤0.01% 6357
2023
Q3 		$1.24M Buy
220,300
+47,900
+28% +$319K ﹤0.01% 6131
2023
Q2 		$952K Buy
172,400
+900
+0.5% +$4.84K ﹤0.01% 6565
2023
Q1 		$1.07M Sell
171,500
-149,500
-47% -$833K ﹤0.01% 6623
2022
Q4 		$1.5M Sell
321,000
-43,800
-12% -$216K ﹤0.01% 6037
2022
Q3 		$1.7M Sell
364,800
-66,800
-15% -$421K ﹤0.01% 5895
2022
Q2 		$2.56M Sell
431,600
-26,400
-6% -$294K ﹤0.01% 5053
2022
Q1 		$8.85M Buy
458,000
+174,400
+61% +$4M ﹤0.01% 3149
2021
Q4 		$9.27M Sell
283,600
-201,300
-42% -$8.1M ﹤0.01% 3206
2021
Q3 		$19.9M Buy
484,900
+69,700
+17% +$2.53M ﹤0.01% 1996
2021
Q2 		$15M Buy
415,200
+261,400
+170% +$9.65M ﹤0.01% 2477
2021
Q1 		$6M Buy
153,800
+58,500
+61% +$2.63M ﹤0.01% 3868
2020
Q4 		$3.84M Buy
+95,300
New +$4.38M ﹤0.01% 4144

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Citadel Advisors's GDRX Position: Q1 2026 in Review

Citadel Advisors increased its GoodRx Holdings (GDRX) stake by 568% in Q1 2026, buying an estimated $454K and bringing the position to 227,583 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #9568.

Citadel Advisors first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $10.7M in Q2 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Citadel Advisors held 227,583 shares of GoodRx Holdings worth $446K as of Q1 2026.
  • Citadel Advisors bought 193,529 GoodRx Holdings shares in Q1 2026, an estimated $454K.
  • GoodRx Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9568 holding.
  • Citadel Advisors first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • Citadel Advisors's GoodRx Holdings position peaked at $10.7M in Q2 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.